M&A HR Support for Pharma & Life Sciences
Your next acquisition's value depends on the people you're acquiring.
Every pharma acquisition in Europe comes with a workforce governed by country-specific labor laws, collective agreements, and employment protections your US team may not fully understand. Mishandling the people side, from pre-deal due diligence to Day 1 readiness to post-close integration – puts key talent, compliance, and deal value at risk.
Europe HR Solutions provides end-to-end M&A HR support for pharma and life sciences companies acquiring across Europe, so your integration moves at the speed of the deal, not the speed of your overstretched HR team.
Clients
Countries
Years Experience
Team Members
The Problem We Solve
Most pharma companies treat HR integration as a workstream that can be handled by existing HRBPs after the deal closes.
In Europe, this approach fails.
European employment laws govern every aspect of how acquired employees are managed – from contract terms and notice periods to works council consultation and collective bargaining obligations. These rules vary in every country, change frequently, and carry significant financial penalties for non-compliance. And in pharma, the workforce itself carries additional complexity: clinical research staff working cross-border, pharmacovigilance teams with regulatory reporting obligations, and scientists whose retention is critical to realizing the deal thesis.
Without dedicated M&A HR support, pharma acquirers frequently face:
Key talent leaving within 6–12 months because nobody communicated clearly or addressed their concerns
Employment contracts that don't comply with local law, creating termination exposure the deal model didn't price in
Works council consultations that stall restructuring timelines by months
Payroll and benefits fragmentation that takes years to untangle
Compliance gaps surfacing during post-deal audits or regulatory inspections
HRBPs burning out because they're running integration AND day-to-day operations simultaneously
Who This Service Is For
Typical clients include:
Global pharma companies acquiring European biotech or specialty pharma targets
Life sciences companies integrating acquired teams across 3–10+ European countries
Serial acquirers who need a repeatable M&A HR framework rather than starting from scratch each deal
VP HR / CHRO teams whose HRBPs are at capacity and can't absorb another integration
Integration leads (PMI) who need the HR workstream unblocked
Typical situations include:
Pre-deal HR due diligence - workforce cost modeling, hidden liabilities, collective agreement risk
Day 1 readiness - employee communications, contract continuity, immediate compliance obligations
Post-close integration - contract harmonization, payroll consolidation, policy standardization
Retained support - ongoing HR compliance management for acquired entities post-integration
Talent retention - structuring stay bonuses, clarifying career paths, and managing employee anxiety during transition
If your deal involves European employees and your HR team doesn’t have the bandwidth or the local expertise to manage the integration, this service exists to fill that gap.
What Our M&A HR Support Covers
Pre-Deal HR Due Diligence
Senior-level workforce risk assessment before the deal closes. We review employment contracts, collective agreements, works council obligations, payroll structures, benefits commitments, pending disputes, and key-person dependencies, and deliver a risk-rated findings report that feeds directly into your deal model and negotiation strategy. Specific to pharma: we flag cross-border employment structures for CRAs, MSLs, and pharmacovigilance staff that may create regulatory or compliance complications post-close.
Day 1 Readiness & Employee Communications
Structured preparation so the acquired workforce isn’t left in a vacuum on Day 1. We draft compliant employee communications, prepare transfer documentation (TUPE-equivalent where applicable), establish interim HR governance, and ensure all immediate compliance obligations (payroll continuity, benefits enrollment, statutory notifications) are met. In pharma, Day 1 failure means key scientists start looking for the exit.
Post-Close Contract & Policy Harmonization
Country-by-country alignment of employment contracts, employee handbooks, HR policies, and workplace rules between the acquiring company’s standards and the acquired entity’s existing framework. We identify what can be harmonized immediately, what requires consultation with employee representatives, and what needs to remain local, and build the phased roadmap to get there. We ensure all changes comply with TUPE protections, acquired rights directives, and local labor law constraints.
Payroll, Benefits & Compliance Integration
Consolidation of payroll providers, benefits structures, social security obligations, and statutory contributions across all acquired countries. We audit current payroll accuracy, flag misalignments between contracts and actual administration, coordinate provider transitions, and ensure ongoing compliance with evolving regulations, including the EU Pay Transparency Directive (June 2026), GDPR data handling requirements, and country-specific reporting obligations.
Why choose us?
M&A HR Expertise Designed for Pharma
Pharma & Life Sciences Focus
M&A HR isn’t generic – pharma workforces have structures that general HR consultants don’t understand. We know how to contract cross-border CRAs, manage MSL employment across jurisdictions, and handle pharmacovigilance team transfers where regulatory continuity is non-negotiable. Our client portfolio – BridgeBio, Everbridge, Epredia, Cipla, AngioDynamics, Genea BioMedx – reflects deep, ongoing life sciences experience, not a one-off project.
Full M&A Lifecycle, Same Team
We don’t hand you a DD memo and disappear. The same team that assessed workforce risk pre-deal manages Day 1 readiness, runs post-close integration, and stays for retained support. No handoff, no re-briefing a new vendor, no knowledge loss. For serial acquirers, this means a partner who already knows your integration playbook and gets faster with every deal.
Capacity Your HRBP Team Doesn't Have
Your HRBPs are already running multi-country operations. Dropping an integration on top of their day-to-day work means both suffer. We become the dedicated M&A HR workstream, operating alongside your HRBPs, not replacing them, so integration moves forward without compromising ongoing HR service delivery.
Success Stories
Long-term partnerships built on trust, expertise, and regulatory reliability across Europe.
I’ve been using Europe HR Solutions in countries where the team size doesn’t justify hiring a local HR professional, allowing us to maintain a lean HR organization. This solution has been fantastic, offering a high level of expertise. Not only do I benefit from exceptional support, but the HR consultants also provide valuable insights into best practices. The team is engaged, available, and knowledgeable. I highly recommend their services to any company seeking top-quality HR support.
Anouck Cerdan Boillat
Head of People, International, BridgeBio
One partner.
Full M&A HR control.
Europe HR Solutions acts as your dedicated M&A HR partner across Europe, providing senior-level support across every phase of the deal – from due diligence through integration and beyond.
• Pre-deal workforce risk assessment across all target countries
• Day 1 readiness and compliant employee communications
• Post-close contract, payroll, and policy harmonization
• Scalable support for serial acquirers doing multiple deals per year
Mishandling the HR side of an acquisition doesn’t just create compliance risk. It destroys the deal value you paid for. Key scientists leave. Integration stalls. Regulatory obligations are missed. We make sure that doesn’t happen.
Frequently Asked Questions For Manufacturing Acquirers
Our M&A legal counsel handles HR due diligence. Why do we need a separate HR partner?
We've done several European acquisitions before. We have an integration playbook.
Most pharma integration playbooks cover IT, finance, commercial, and regulatory, but the HR workstream is a checklist, not a methodology. If your HR integration consistently takes 12–18 months, if you’re losing key talent in the first 6 months, or if your HRBPs are telling you they can’t absorb another deal – the playbook has a gap. EHRS fills it with dedicated M&A HR capacity and local expertise your playbook can’t replicate.
How quickly can you mobilize? We're in active due diligence right now.
We can start within 1–2 weeks. For pre-deal DD, we work within your timeline and data room constraints. For post-close integration, we build a 30/60/100-day plan and begin executing immediately. Speed matters in pharma M&A – every week of uncertainty increases the chance that acquired scientists and key commercial staff start taking calls from recruiters.
Can you support multiple acquisitions in the same year?
Yes – and this is where the model becomes most efficient. After the first deal, we already know your employment standards, your integration preferences, and your HRBP team. Each subsequent deal ramps faster because we’re not starting from zero. For serial acquirers, EHRS becomes a standing M&A HR capability.
Can you support multiple acquisitions in the same year?
Yes – and this is where the model becomes most efficient. After the first deal, we already know your employment standards, your integration preferences, and your HRBP team. Each subsequent deal ramps faster because we’re not starting from zero. For serial acquirers, EHRS becomes a standing M&A HR capability.
What does this cost?
It depends on deal scope – number of countries, headcount, complexity, and which phases you need (DD only, DD + Day 1, full lifecycle). We scope every engagement individually. Book a free consultation and we’ll provide a detailed proposal within a week. Context: the cost of our support is a fraction of what one mishandled termination, one failed works council consultation, or one key-person departure costs a pharma acquisition.
Reduce HR risk in your next acquisition. Start with a conversation.
Not sure where to start?
Talk to a HR expert.
Whether you’re in active due diligence, preparing for Day 1, mid-integration, or planning your next deal – a short conversation can bring immediate clarity.
Our role is not to sell a generic service, but to understand your specific deal, your workforce, and your HR team’s capacity – and outline the most effective next steps.
No obligation, no pressure – just clear, practical guidance from senior HR professionals who work with pharma and life sciences companies acquiring in Europe every day.